Orexin-induced hyperlocomotion and stereotypy are mediated by the dopaminergic system

Brain Research

Volumn 873, Issue 1, 2000, Pages 181-187

  Nakamura, Toshiaki ^a   Uramura, Kazuhide ^b   Nambu, Tadahiro ^a   Yada, Toshihiko ^b,c   Goto, Katsutoshi ^a   Yanagisawa, Masashi ^d   Sakurai, Takeshi ^a  

^a Department of Biochemistry   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Hyperlocomotion; Orexin; Stereotypy, Dopamine; Ventral tegmental area

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; HALOPERIDOL; OREXIN A; SULPIRIDE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STEREOTYPY; VENTRAL TEGMENTUM;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; AXONS; BEHAVIOR, ANIMAL; CARRIER PROTEINS; DOPAMINE; DOPAMINE ANTAGONISTS; HALOPERIDOL; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MOTOR ACTIVITY; NERVE ENDINGS; NEURONS; NEUROPEPTIDES; RATS; RATS, WISTAR; STEREOTYPED BEHAVIOR; SULPIRIDE; TEGMENTUM MESENCEPHALI; TYROSINE 3-MONOOXYGENASE;

EID: 0034604826     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02555-5     Document Type: Article

References (24)

1. Berridge K.C., Robinson T.E. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res. Brain Res. Rev. 28:1998;309-369.
2. Braun A.R., Laruelle M., Mouradian M.M. Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications. J. Neural Transm. 104:1997;341-362.
3. Cai X.J., Widdowson P.S., Harrold J., Wilson S., Buckingham R.E., Arch J.R., Tadayyon M., Clapham J.C., Wilding J., Williams G. Hypothalamic orexin expression: modulation by blood glucose and feeding. Diabetes. 48:1999;2132-2137.
4. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., Richardson J.A., Williams S.C., Xiong Y., Kisanuki Y., Fitch T.E., Nakazato M., Hammer R.E., Saper C.B., Yanagisawa M. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell. 98:1999;437-451.
5. Date Y., Ueta Y., Yamashita H., Yamaguchi H., Matsukura S., Kangawa K., Sakurai T., Yanagisawa M., Nakazato M. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc. Natl. Acad. Sci. USA. 96:1999;748-753.
6. de Lecea L., Kilduff T.S., Peyron C., Gao X.-B., Foye P.E., Danielson P.E., Fukuhara C., Battenberg E.L., Gautvik V.T., Bartlett 2nd F.S., Frankel W.N., van den Pol A.N., Bloom F.E., Gautvik K.M., Sutcliffe J.G. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. USA. 95:1998;322-327.
7. Dougherty G., Ellinwood E. Influence of gamma-butyrolactone on behavior due to dopaminergic drugs. Physiol. Behav. 30:1983;607-612.
8. Hagan J.J., Leslie R.A., Patel S., Evans M.L., Wattam T.A., Holmes S., Benham C.D., Taylor S.G., Routledge C., Hemmati P., Munton R.P., Ashmeade T.E., Shah A.S., Hatcher J.P., Hatcher P.D., Jones D.N., Smith M.I., Piper D.C., Hunter A.J., Porter R.A., Upton N. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc. Natl. Acad. Sci. USA. 96:1999;10911-10916.
9. Ida T., Nakahara K., Katayama T., Murakami N., Nakazato M. Effect of lateral cerebroventricular injection of the appetite-stimulating neuropeptide, orexin and neuropeptide Y, on the various behavioral activities of rats. Brain Res. 821:1999;526-529.
10. Kunii K., Yamanaka A., Nambu T., Matsuzaki I., Goto K., Sakurai T. Orexins/hypocretins regulate drinking behavior. Brain Res. 842:1999;256-261.
11. Lin L., Faraco J., Li R., Kadotani H., Rogers W., Lin X., Qiu X., de Jong P.J., Nishino S., Mignot E. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell. 98:1999;365-376.
12. Miller J.D., Faull K.F., Bowersox S.S., Dement W.C. CNS monoamines and their metabolites in canine narcolepsy: a replication study. Brain Res. 509:1990;169-171.
13. Moriguchi T., Sakurai T., Nambu T., Yanagisawa M., Goto K. Neurons containing orexin in the lateral hypothalamic area of the adult rat brain are activated by insulin-induced acute hypoglycemia. Neurosci. Lett. 264:1999;101-104.
14. Muroya S., Yada T., Shioda S., Takigawa M. Glucose-sensitive neurons in the rat arcuate nucleus contain neuropeptide Y. Neurosci. Lett. 264:1999;113-116.
15. Nambu T., Sakurai T., Mizukami K., Hosoya Y., Yanagisawa M., Goto K. Distribution of orexin neurons in the adult rat brain. Brain Res. 827:1999;243-260.
16. Nishino S., Arrigoni J., Valtier D., Miller J.D., Guilleminault C., Dement W.C., Mignot E. Dopamine D2 mechanisms in canine narcolepsy. J. Neurosci. 11:1991;2666-2671.
17. Oomura Y. Input-output organization in the hypothalamus relating to food intake behavior. Morgane P.J., Panksepp J. Handbook of the Hypothalamus. Physiology of the Hypothalamus. Vol. 2:1980;557-620 Marcel Dekker, New York.
18. Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G., Kilduff T.S. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 18:1998;9996-10015.
19. Reid M.S., Tafti M., Nishino S., Sampathkumaran R., Siegel J.M., Mignot E. Local administration of dopaminergic drugs into the ventral tegmental area modulates cataplexy in the narcoleptic canine. Brain Res. 733:1996;83-100.
20. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richardson J.A., Kozlowski G.P., Wilson S., Arch J.R., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., McNulty D.E., Liu W.S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 92:1998;573-585.
21. Schwarting R.K., Huston J.P. The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments. Prog. Neurobiol. 50:1996;275-331.
22. Strittmatter M., Isenberg E., Grauer M.T., Hamann G., Schimrigk K. CSF substance P somatostatin and monoaminergic transmitter metabolites in patients with narcolepsy. Neurosci. Lett. 218:1996;99-102.
23. Williams S.M., Goldman-Rakic P.S. Widespread origin of the primate mesofrontal dopamine system. Cereb. Cortex. 8:1998;321-345.
24. Zhou Q.Y., Palmiter R.D. Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell. 83:1995;1197-1209.